17-(CYCLOPROPYLMETHYL)-6,7-DEHYDRO-4,5-EPOXY-3-BENZYLOXY-14-HYDROXY-6,7,2',3'-INDOLOMORPHINAN

Englisch Name:: 17-(CYCLOPROPYLMETHYL)-6,7-DEHYDRO-4,5-EPOXY-3-BENZYLOXY-14-HYDROXY-6,7,2',3'-INDOLOMORPHINAN

Synonyma:: 3-BNTI;3-O-BENZYL-NALTRINDOLE BASE;17-(Cyclopropylmethyl)-6,7-dehydro-4,5a-epoxy-3-benzyloxy-14-hydroxy-6,7,23indolomorphinan;17-(CYCLOPROPYLMETHYL)-6,7-DEHYDRO-4,5-EPOXY-3-BENZYLOXY-14-HYDROXY-6,7,2',3'-INDOLOMORPHINAN;4,8-Methanobenzofuro[2,3-a]pyrido[4,3-b]carbazol-8a(9H)-ol, 7-(cyclopropylmethyl)-5,6,7,8,14,14b-hexahydro-1-(phenylmethoxy)-, (4bS,8R,8aS,14bR)-;4,8-methanobenzofuro(2,3-a(pyrido(4,3-b(carbazol-8a(9H)-ol, 7-(cyclopropylmethyl)-5,6,7,8,14,14b-hexahydro-1-(phenylmethoxy-), (8R-(4bS*, 8.a, 8a.beta,14b.beta);4,8-METHANOBENZOFURO[2,3-A]PYRIDO[4,3-B]CARBAZOL-8A(9H)-OL, 7-(CYCLOPROPYLMETHYL)-5,6,7,8,14,14B-HEXAHYDRO-1-(PHENYLMETHOXY-), [8R-(4BS*, 8-ALPHA, 8A-BETA,14B-BETA)]

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 2

17-(CYCLOPROPYLMETHYL)-6,7-DEHYDRO-4,5-EPOXY-3-BENZYLOXY-14-HYDROXY-6,7,2',3'-INDOLOMORPHINAN Eigenschaften

Yellowish solid

Naltrindol 17-(cyclopropylmethyl)-7-benzyl-4,5-epoxy-3,14-dihydroxymorphinan-6-one α-Bromtoluol Naltrexone Phenylhydraziniumchlorid

Global( 2)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Jinan Ruisi Pharmaceutical Technology Co., LTD	0531-0531-69900633 19963472814	changyuan20@163.com	China	5558	58

17-(CYCLOPROPYLMETHYL)-6,7-DEHYDRO-4,5-EPOXY-3-BENZYLOXY-14-HYDROXY-6,7,2',3'-INDOLOMORPHINAN
4,8-METHANOBENZOFURO[2,3-A]PYRIDO[4,3-B]CARBAZOL-8A(9H)-OL, 7-(CYCLOPROPYLMETHYL)-5,6,7,8,14,14B-HEXAHYDRO-1-(PHENYLMETHOXY-), [8R-(4BS*, 8-ALPHA, 8A-BETA,14B-BETA)]
3-O-BENZYL-NALTRINDOLE BASE
3-BNTI
17-(Cyclopropylmethyl)-6,7-dehydro-4,5a-epoxy-3-benzyloxy-14-hydroxy-6,7,23indolomorphinan
4,8-methanobenzofuro(2,3-a(pyrido(4,3-b(carbazol-8a(9H)-ol, 7-(cyclopropylmethyl)-5,6,7,8,14,14b-hexahydro-1-(phenylmethoxy-), (8R-(4bS*, 8.a, 8a.beta,14b.beta)
4,8-Methanobenzofuro[2,3-a]pyrido[4,3-b]carbazol-8a(9H)-ol, 7-(cyclopropylmethyl)-5,6,7,8,14,14b-hexahydro-1-(phenylmethoxy)-, (4bS,8R,8aS,14bR)-
161532-22-5